Control of ACTH secretion by excitatory amino acids functional significance and clinical implications

Endocrine

Volumn 28, Issue 3, 2005, Pages 287-293

  Jezova, Daniela ^a  

^a INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

Author keywords

ACTH; Cortisol; Depression; Drug abuse; Glutamate; Stress

Indexed keywords

2 AMINO 2 (2 CARBOXYCYCLOPROPYL) 3 (XANTHEN 9 YL)PROPIONIC ACID; 4 AMINO 2 OXABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; ACAMPROSATE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOZAPINE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR DERIVATIVE; DEXAMETHASONE; DEXTROMETHORPHAN; DIZOCILPINE; EXCITATORY AMINO ACID; FELBAMATE; GLUCOCORTICOID; GLUTAMATE RECEPTOR AGONIST; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID; GYK 152466; HYDROCORTISONE; KAINIC ACID RECEPTOR ANTAGONIST; KETAMINE; LAMOTRIGINE; MEMANTINE; MOOD STABILIZER; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; PHENYTOIN; RILUZOLE; TIANEPTINE; UNINDEXED DRUG;

ALZHEIMER DISEASE; CORTICOTROPIN RELEASE; DEPRESSION; DRUG ABUSE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MEDICAL INFORMATION; MENTAL DISEASE; NEUROENDOCRINE DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; STRESS; UNSPECIFIED SIDE EFFECT;

EID: 29944444418     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1385/ENDO:28:3:287     Document Type: Review

References (83)

1. Makara, G. B. and Stark, E. (1975). Neuroendocrinology 18, 213-216.
2. Gay, V. L. and Plant, T. M. (1987). Endocrinology 120, 2289-2296.
3. Farah, J. M. Jr., Rao, T. S., Mick, S. J., Coyne, K. E., and Iyengar, S. (1991). Endocrinology 128, 1875-1880.
4. Jezova, D., Oliver, C., and Jurcovicova, J. (1991). Neuroendocrinology 54, 488-492.
5. Yousef, K. A., Tepper, P. G., Molina, P. E., Abumrad, N. N., and Lang, C. H. (1994). Brain Res. 634, 131-140.
6. Pechnick, R. N., George, R., and Poland, R. E. (1989). Eur. J. Pharmacol. 164, 257-263.
7. Jezova, D., Tokarev, D., and Rusnak, M. (1995). Neuroendocrinology 62, 326-332.
8. Pechnick, R. N. and Poland, R. E. (2004). J. Pharmacol. Exp. Ther. 309, 515-522.
9. Tokarev, D. and Jezova, D. (1997). Methods Find. Exp. Clin. Pharmacol. 19, 323-328.
10. Zelena, D., Makara, G. B., and Jezova, D. (1999). Neuroendocrinology 69, 316-323.
11. Broadbear, J. H., Winger, G., and Woods, J. H. (2004). Psychopharmacology (Berlin) 176, 398-406.
12. Lang, C. H. and Ajmal, M. (1995). Am. J. Physiol. 268, R1026-R1033.
13. Johnson, M. P., Kelly, G., and Chamberlain, M. (2001). J. Neuroendocrinol. 13, 670-677.
14. Scaccianoce, S., Matrisciano, F., Del Bianco, P., et al. (2003). Neuropharmacology 44, 555-561.
15. Bradbury, M. J., Giracello, D. R., Chapman, D. F., et al. (2003). Neuropharmacology 44, 562-572.
16. Aubry, J. M., Bartanusz, V., Pagliusi, S., Schulz, P., and Kiss, J. Z. (1996). Neurosci. Lett. 205, 95-98.
17. Herman, J. P., Eyigor, O., Ziegler, D. R., and Jennes, L. (2000). J. Comp. Neurol. 422, 352-362.
18. Kocsis, K., Kiss, J., Gorcs, T., and Halasz, B. (1998). Neuroreport 9, 4029-4033.
19. Herman, J. P., Mueller, N. K., and Figueiredo, H. (2004). Ann. NY Acad. Sci. 1018, 35-45.
20. Hrabovszky, E., Wittmann, G., Turi, G. F., Liposits, Z., and Fekete, C. (2005). Endocrinology 146, 341-347.
21. Joanny, P., Steinberg, J., Oliver, C., and Grino, M. (1997). J. Neuroendocrinol. 9, 93-97.
22. Zelena, D., Mergl, Z., and Makara, G. B. (2005). Brain Res. 1031, 185-193.
23. Jezova, D., Vigas, M., Bartanusz, V., Reymond, M. J., and Zorad, S. (1996). In: Stress: molecular genetic and neurobiological advances. McCarty, R., Aguilera, G., Sabban, E., and Kvetnansky R. (eds.). Gordon and Breach Science Publishers: New York, pp. 417-430.
24. Jezova, D. and Schwendt, M. (2005). In: Glutamate receptors in peripheral tissue: excitatory transmission outside the CNS. Gill, S. and Pulido O. (eds.). Kluwer Academic/Plenum Publishers: New York, pp. 169-178.
25. Lowy, M. T., Gault, L., and Yamamoto, B. K. (1993). J. Neurochem. 61, 1957-1960.
26. Moghaddam, B. (1993). J. Neurochem. 60, 1650-1657.
27. Bartanusz, V., Aubry, J. M., Pagliusi, S., Jezova, D., Baffi, J., and Kiss, J. Z. (1995). Neuroscience 66, 247-252.
28. Fitzgerald, L. W., Ortiz, J., Hamedani, A. G., and Nestler, E. J. (1996). J. Neurosci. 16, 274-282.
29. Schwendt, M. and Jezova, D. (2000). Cell. Mol. Neurobiol. 20, 319-329.
30. Akinbami, M. A., Philip, G. H., Sridaran, R., Mahesh, V. B., and Mann, D. R. (1999). J. Steroid Biochem. Mol. Biol. 70, 143-149.
31. Reagan, L. P., Rosell, D. R., Wood, G. E., et al. (2004). Proc. Natl. Acad. Sci. USA 101, 2179-2184.
32. Boudouresque, F., Chautard, T., Jezova, D., et al. (1991). Endocr. Regul. 25, 44-52.
33. Skultetyova, I., Tokarev, D. I., and Jezova, D. (1993). Endocr. Regul. 27, 209-213.
34. Olney, J. W. (1969). Science 164, 719-721.
35. Skultetyova, I., Kiss, A., and Jezova, D. (1998). Neuroendocrinology 67, 412-420.
36. Leret, M. L., Peinado, V., Suarez, L. M., Tecedor, L., Gamallo, A., and Gonzalez, J. C. (2004). Int. J. Dev. Neurosci. 22, 87-93.
37. Chautard, T., Boudouresque, F., Guillaume, V., and Oliver, C. (1993). Neuroendocrinology 57, 70-78.
38. Kent, S., Kernahan, S. D., and Levine, S. (1996). Brain Res. Dev. Brain Res. 94, 1-13.
39. Jezova, D., Kiss, A., Tokarev, D., and Skultetyova, I. (1998). Stress Med. 14, 255-260.
40. Makatsori, A., Dubovicky, M., Ujhazy, E., Bakos, J., and Jezova, D. (2005). Neurotoxicol. Teratol. 27, 509-514.
41. Jezova, D., Skultetyova, I., Makatsori, A., Moncek, F., and Duncko, R. (2002). Stress 5, 177-183.
42. Bakos, J., Duncko, R., Makatsori, A., Pirnik, Z., Kiss, A., and Jezova, D. (2004). Ann. NY Acad. Sci. 1018, 281-287.
43. Kendell, S. F., Krystal, J. H., and Sanacora, G. (2005). Expert. Opin. Ther. Targets 9, 153-168.
44. Tichomirowa, M. A., Keck, M. E., Schneider, H. J., et al. (2005). J. Endocrinol. Invest. 28, 89-99.
45. Stahl, S. M. and Grady, M. M. (2003). J. Clin. Psychiatry 64 (Suppl. 13), 13-17.
46. Duncko, R., Schwendt, M., and Jezova, D. (2003). Pharmacol. Biochem. Behav. 76, 9-16.
47. Strohle, A. and Holsboer, F. (2003). Pharmacopsychiatry 36 (Suppl. 3), S207-S214.
48. Reid, I. C. and Stewart, C. A. (2004). Neurotox. Res. 6, 483-489.
49. McEwen, B. S. and Olie, J. P. (2005). Mol. Psychiatry 10, 525-537.
50. Delbende, C., Tranchand, B. D., Tarozzo, G., et al. (1994). Eur. J. Pharmacol. 251, 245-251.
51. Jezova, D. and Duncko, R. (2002). J. Psychopharmacol.. 16, 235-240.
52. Du, J., Gray, N. A., Falke, C. A., et al. (2004). J. Neurosci. 24, 6578-6589.
53. Zarate, C. A. Jr., Quiroz, J. A., Singh, J. B., et al. (2005). Biol. Psychiatry 57, 430-432.
54. Kniest, A., Wiesenberg, C., Weber, B., Colla, M., Heuser, I., and Deuschle, M. (2001). Neuropsychobiology 43, 91-95.
55. Makatsori, A., Duncko, R., Moncek, F., Loder, I., Katina, S., and Jezova, D. (2004). Neuroendocrinology 79, 34-42.
56. Pistovcakova, J., Makatsori, A., Sulcova, A., and Jezova, D. (2005). Eur. Neuropsychopharmacol. 15, 153-158.
57. Tzschentke, T. M. and Schmidt, W. J. (2003). Mol. Psychiatry 8, 373-382.
58. Schmidt, E. D., Tilders, F. J., Janszen, A. W., Binnekade, R., De Vries, T. J., and Schoffelmeer, A. N. (1995). Eur. J. Pharmacol. 285, 317-321.
59. Jezova, D., Mlynarik, M., Zelena, D., and Makara, G. B. (2004). Brain Res. 1021, 63-68.
60. Kim, J. H., Austin, J. D., Tanabe, L., Creekmore, E., and Vezina, P. (2005). Eur. J. Neurosci. 21, 295-300.
61. Torres, G., Rivier, C., and Weiss, F. (1994). Brain Res. 656, 33-42.
62. Makatsori, A., Duncko, R., Schwendt, M., Moncek, F., Johansson, B. B., and Jezova, D. (2003). Psychoneuroendocrinology 28, 702-714.
63. Schwendt, M., Duncko, R., Makatsori, A., Moncek, F., Johansson, B. B., and Jezova, D. (2003). Neurochem. Res. 28, 653-657.
64. Nakagawa, T. and Satoh, M. (2004). Ann. NY Acad. Sci. 1025, 383-388.
65. Le Greves, P., Huang, W., Zhou, Q., Thornwall, M., and Nyberg, F. (1998). Eur. J. Pharmacol. 341, 161-164.
66. Zhu, H., Jang, C. G., Ma, T., Oh, S., Rockhold, R. W., and Ho, I. K. (1999). Eur. J. Pharmacol. 365, 47-54.
67. Pirnik, Z., Schwendt, M., and Jezova, D. (2001). Endocr. Regul. 35, 187-193.
68. Nagy, J. (2004). Drugs 7, 339-350.
69. Scott, L. J., Figgitt, D. P., Keam, S. J., and Waugh, J. (2005). CNS Drugs 19, 445-464.
70. Zimmerman, U., Spring, K., Koller, G., Holsboer, F., and Soyka, M. (2004). Pharmacopsychiatry 37, 98-102.
71. Elman, I., Lukas, S. E., Karlsgodt, K. H., Gasic, G. P., and Breiter, H. C. (2003). Psychopharmacol. Bull. 37, 84-89.
72. McCullumsmith, R. E., Clinton, S. M., and Meador-Woodruff, J. H. (2004). Int. Rev. Neurobiol. 59, 19-45.
73. Javitt, D. C. (2004). Mol. Psychiatry 9, 984-997.
74. Zhang, X. Y., Zhou, D. F., Cao, L. Y., Wu, G. Y., and Shen, Y. C. (2005). Neuropsychopharmacology 30, 1532-1538.
75. Altamura, A. C., Boin, F., and Maes, M. (1999). Eur. Neuropsychopharmacol. 10, 1-4.
76. Hynd, M. R., Scott, H. L., and Dodd, P. R. (2004). Neurochem. Int. 45, 583-595.
77. Farlow, M. R. (2004). Geriatrics 59, 22-27.
78. Pascualy, M., Petrie, E. C., Brodkin, K., Peskind, E. R., Wilkinson, C. W., and Raskind, M. A. (2000). Biol. Psychiatry 48, 247-254.
79. Zhou, Y., Yuferov, V. P., Spangler, R., Maggos, C. E., Ho, A., and Kreek, M. J. (1998). Eur. J. Pharmacol. 352, 65-71.
80. Hergovich, N., Singer, E., Agneter, E., et al. (2001). Neuropsychopharmacology 24, 590-593.
81. Murck, H., Struttmann, T., Czisch, M., Wetter, T., Steiger, A., and Auer, D. P. (2002). Neuropsychobiology 45, 120-123.
82. van Berckel, B. N., Lipsch, C., Gispen-de Wied, C., et al. (1998). Psychopharmacology (Berlin) 138, 190-197.
83. Deuster, P. A., Faraday, M. M., Chrousos, G. P., and Poth, M. A. (2005). J. Clin. Endocrinol. Metab. 90, 4777-4783.